$1.50
+0 (+0%)
At Close: Jun 23, 2026
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
06:15pm, Friday, 22'nd Sep 2023
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufact
InMed to Present at H.C. Wainwright 25th Annual Global Investment Conference
08:30am, Thursday, 07'th Sep 2023
Vancouver, British Columbia--(Newsfile Corp. - September 7, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufactu
Sign In
Buy INM